<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04930120</url>
  </required_header>
  <id_info>
    <org_study_id>20 CO 015 CZ</org_study_id>
    <nct_id>NCT04930120</nct_id>
  </id_info>
  <brief_title>Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units</brief_title>
  <acronym>TRANSCOV</acronym>
  <official_title>TRANSCOV Cohort. An Epidemiological Study Assessing the Impact of Critically Ill COVID-19 Patients Long Distance Transfers Between Intensive Care Units</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ecole des Hautes Etudes en Santé Publique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ecole des Hautes Etudes en Santé Publique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The TRANSCOV cohort is a multicentre observational retrospective study aiming at assessing&#xD;
      the health impact of extra regional transfers of critically ill COVID-19 patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In spring 2020 four regions of France faced a surge of severe Coronavirus (COVID) patients&#xD;
      which threatened to overflow local intensive care units (ICU) capacities. As an emergency&#xD;
      response, between 03/13/2020 and 04/10/2020, an estimated 661 patients were transferred from&#xD;
      overcrowded ICUs to other French regions and neighbouring countries. The study aims at&#xD;
      assessing the impact of these inter-ICU transfers on the short and medium term physical and&#xD;
      psychological outcomes in this population of severe COVID 19 patients.&#xD;
&#xD;
      All transferred patients between ICUs outside the origin region are invited to take part. For&#xD;
      each transfer, up to four control patients will be selected among those admitted in the same&#xD;
      ICU during the same period (+/-4 days of transfer date). Clinical data will be extracted from&#xD;
      medical records and will include hemodynamic and respiratory parameters, as well as clinical&#xD;
      severity scores before, during and after transfer. Data linkage with medico-administrative&#xD;
      data will enrich the clinical database and allow follow-up up to one year after initial&#xD;
      admission.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>1 year</time_frame>
    <description>Status alive or dead</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3060</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Transferred group</arm_group_label>
    <description>The transferred group includes all severe COVID patients admitted in a French ICU ward and then transferred between the 03/13/2020 and 04/10/2020 to another ICU located outside the region of the initial ICU stay.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>The control group includes patients selected out of those whose entire ICU care has taken place in one of the hospitals which transferred patients. Up to 4 control patients will be selected for each transferred patient.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inter ICU long distance patient transfer</intervention_name>
    <description>Individual or grouped transportation between ICU of severely ill patients using ambulance, plane, helicopter, train or boat, with specialist medical assistance.</description>
    <arm_group_label>Transferred group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Severely ill COVID-19 patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 patients diagnosed biologically or by imaging&#xD;
&#xD;
          -  Admission in ICU between 03/13/2020 and 04/10/2020&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Olivier Grimaud, Ph.D., M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ecole des Hautes Etudes en Santé Publique</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olivier Grimaud, Ph.D., M.D</last_name>
    <phone>02 99 02 28 34</phone>
    <phone_ext>33</phone_ext>
    <email>olivier.grimaud@ehesp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christophe Fermanian, Ph.D.</last_name>
    <phone>02 99 02 24 69</phone>
    <phone_ext>33</phone_ext>
    <email>christophe.fermanian@ehesp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>EHESP</name>
      <address>
        <city>Rennes</city>
        <zip>35043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Grimaud, Ph.D., M.D.</last_name>
      <phone>02 99 02 2834</phone>
      <phone_ext>33</phone_ext>
      <email>olivier.grimaud@ehesp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Christophe Fermanian, Ph.D.</last_name>
      <phone>02 99 02 24 69</phone>
      <phone_ext>33</phone_ext>
      <email>christophe.fermanian@ehesp.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 17, 2021</last_update_submitted>
  <last_update_submitted_qc>June 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ecole des Hautes Etudes en Santé Publique</investigator_affiliation>
    <investigator_full_name>Olivier Grimaud</investigator_full_name>
    <investigator_title>Head of the deparment Quantitative Methods in Public Health</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

